Skip to content

New Serological Markers for Eosinophilic Esophagitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01624129
Enrollment
20
Registered
2012-06-20
Start date
2011-01-31
Completion date
Unknown
Last updated
2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Esophagitis

Brief summary

The purpose of the study is to investigate if serological parameters such as extracellular Serum-Tryptase (ST) and eosinophilic cationic protein (ECP) are useful for the diagnosis and surveillance of the eosinophilic esophagitis (EE).

Detailed description

The eosinophilic esophagitis (EE) is chronic inflammatory and immunological disease. The diagnosis of EE is based upon large numbers of eosinophils in the esophagus on histopathologic examination (\> 20 eosinophils per high powered field in at least one specimen) despite acid suppression with a Proton-Pump-Inhibitor (PPI) for at least two weeks. There are no diagnostic serological markers for EE so far, so that the purpose of the study is to investigate serological markers which are established in other allergic diseases.

Interventions

DRUGFluticasone

Guideline-based treatment with fluticasone 0,5 ml (1-0-1), step-up or step-down after 3 months based on the histopathological findings

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* histopathological defined eosinophilic esophagitis * Age: 18-80

Exclusion criteria

* missing consent form * contraindications for performing esophagogastroscopy/taking biopsies of the esophagus

Countries

Germany

Contacts

Primary ContactMonther Bajbouj, MD
monther.bajbouj@lrz.tum.de+49-89-41402450
Backup ContactChristoph Schlag, MD
Christoph.Schlag@lrz.tum.de+49-89-41402450

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026